ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cohort Study"

  • Abstract Number: 0154 • ACR Convergence 2024

    Chronic Sinusitis Predicting Interstitial Lung Disease in Sjögren’s Syndrome: A Comprehensive USA Population Study (2004-2024)

    Brian Schonewald1, Ross summer2, Giorgos Loizidis2 and Christopher Xie3, 1Thomas Jefferson University Hospital, Ardmore, PA, 2Thomas Jefferson University, Philadelphia, PA, 3Thomas Jefferson University, Philadelphia

    Background/Purpose: Sjögren's syndrome (SS) is a chronic autoimmune disorder primarily affecting the exocrine glands, but it also impacts various parts of the respiratory system, including…
  • Abstract Number: 0483 • ACR Convergence 2024

    Obesity, Prednisone Use, and Patient-Reported Outcomes Are Predictors of Becoming Difficult-to-Treat in an RA Population Treated with a First-Line Biologic DMARD

    Misti Paudel1, Shravani Chitineni1, Ruogu Li2, Chinmayi Naik3, Nancy Shadick3, Michael Weinblatt4 and Daniel Solomon5, 1Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women’s Hospital, Boston, MA, 4Brigham and Women's Hospital/ Harvard Medical School, Waban, MA, 5Brigham and Women's Hospital, Newton, MA

    Background/Purpose: Prior studies have evaluated the risk factors for difficult-to-treat RA (D2T-RA) but have not applied EULAR’s full criteria for D2T-RA in a longitudinal data…
  • Abstract Number: 0804 • ACR Convergence 2024

    Serologic and Clinical Predictors of Progressive Pulmonary Fibrosis in Rheumatoid Arthritis-associated Interstitial Lung Disease Progression: A Prospective Longitudinal Cohort

    Sung Hae Chang1, Misti Paudel2, Gregory McDermott3, Qianru Zhang4, You-Jung Ha5, Jeong Seok Lee6, Min Uk Kim7, Chan Ho Park8, Ji-Won Kim9, Jang Woo Ha10, Sang Wan Chung11, Sung Won Lee12, Eun Ha Kang5, Yeon-Ah Lee13, Jung-Yoon Choe14, Yong-Beom Park15, Eun Young Lee16 and Jeffrey Sparks17, and the KOrean Rheumatoid Arthritis Interstitial Lung Disease (KORAIL) group, 1Brigham and Women's Hospital/Soonchunhyang University, College of Medicine, Boston, MA, 2Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, 3Brigham and Women's Hospital, Brookline, MA, 4Harvard medical school, Cambridge, MA, 5Seoul National University Bundang Hospital, Seongnam, South Korea, 6Korea Advanced Institute of Science and Technology, KAIST,, Daejeon, Republic of Korea, 7SMG-SNU Boramae Medical Center, Seoul, Republic of Korea, 8Soonchunhyang University College of Medicine,, Cheonan-si, Republic of Korea, 9Daegu Catholic University School of Medicine, Nam-gu, Daegu, South Korea, 10Yonsei university college of medicine, Seodaemun-gu, Seoul, South Korea, 11Kyung Hee University Hospital, Seoul, Republic of Korea, 12Soonchunhyang University Cheonan Hospital, Seoul, South Korea, 13Kyung Hee University Hospital, Seoul, South Korea, 14Catholic University of Daegu School of Medicine, Daegu, Republic of Korea, 15Yonsei University College of Medicine, Seoul, Republic of Korea, 163Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea, 17Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA

    Background/Purpose: Predictors of progressive pulmonary fibrosis (PPF) in patients with rheumatoid arthritis-associated interstitial lung disease (ILD) are unclear but may be due to inflammation or…
  • Abstract Number: 1185 • ACR Convergence 2024

    Walking Is Associated with Less Knee Pain: A Cross-sectional Study from the Osteoarthritis Initiative

    Sydney Tran1, Jeffrey Driban2, Timothy McAlindon3, Andrea Kriska4, Bonny Rockette-Wagner4, Charles Eaton5, Marc Hochberg6, Kent Kwoh7, Michael Nevitt8 and Grace Lo9, 1Baylor College of Medicine, Houston, 2University of Massachusetts Chan Medical School, Worcester, MA, 3University of Massachusetts Chan Medical School, Worcester, 4University of Pittsburgh, Pittsburgh, PA, 5Warren Alpert Medical School of Brown University, Providence, RI, 6University of Maryland School of Medicine, Cambridge, MD, 7University of Arizona, Tucson, AZ, 8University of California, San Francisco, San Francisco, CA, 9Baylor College of Medicine / MEDVAMC, Houston, TX

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, with the knee being the most common joint involved. Exercise is a leading non-pharmacological treatment…
  • Abstract Number: 1497 • ACR Convergence 2024

    Type I Interferon Status and Clinical Manifestations in a Large Cohort of Patients with Systemic Lupus Erythematosus

    Justin Smith1, Laura Patricia Whittall Garcia2, Dennisse Bonilla2, Qixuan Li2, Robert Terbrueggen3, Hemani Wijesuriya3, Ian Richards3, Aviva Jacobs3, Joan Wither2, Dafna Gladman4 and Zahi Touma5, and DxTerity, 1University of Toronto, Toronto, AB, Canada, 2University Health Network, Toronto, ON, Canada, 3DxTerity Diagnostics Inc., Torrance, CA, 4University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 5University of Toronto, Toronto, ON, Canada

    Background/Purpose: Type I interferons (IFN) are pivotal in the pathogenesis of SLE, with studies showing high IFN gene signature (IGS) status associated with certain organ…
  • Abstract Number: 1900 • ACR Convergence 2024

    Dietary Exposures Associated with Incident Spondyloarthritis

    Griffin Reed, Cynthia Crowson, Ryan Lennon, John Davis and Vanessa Kronzer, Mayo Clinic, Rochester, MN

    Background/Purpose: Studies have shown that diet can modify the risk of developing rheumatoid arthritis [1], but the association between diet and spondyloarthritis (SpA) remains largely…
  • Abstract Number: 2237 • ACR Convergence 2024

    The Association Between Bariatric Surgery and Incident Rheumatoid Arthritis

    Helana Jeries1, Revital Perlov Gavze2, Rula Daood3, Fadi Hassan3, Liat Lev shalem4, Ahmad Assalia5 and Mohammad E Naffaa3, 1Rheumatology Unit, Galilee Medical Center, Naharyia, Israel, Naharyia, HaZafon, Israel, 2Maccabi Healthcare Services, Tel Aviv, Israel, 3Rheumatology Unit, Galilee Medical Center, Naharyia, Israel, Naharyia, Israel, 4Maccabi Healthcare Services, Tel Aviv, HaMerkaz, Israel, 5Rambam Healthcare Campus, Haifa, HaZafon, Israel

    Background/Purpose: Obesity is considered a controversial risk factor for developing rheumatoid arthritis (RA), and the association between weight change and RA incidence is inconclusive. The…
  • Abstract Number: 2497 • ACR Convergence 2024

    Clinical Characteristics and Outcomes of Hydralazine-induced ANCA-associated Vasculitis. a Single Center Retrospective Cohort Analysis from the US

    Muhammad Shamim1, Mazen Allouni2, Haseeb Chaudhary3, Ansaam Daoud4, Loai Dweik5, Hashim Syed6 and Omer Pamuk7, 1University Hospitals/ Case Western Reserve University, Cuyahoga Falls, OH, 2Case Western Reserve, University Hospitals, Cleveland Medical Center, Cleveland, OH, 3Case Western Reserve University, Westlake, OH, 4Case Western Reserve University/University Hospitals, Akron, OH, 5Cleveland Clinic Akron General Internal Medicine, Akron, OH, 6Case Western/ UH, Cleveland, 7University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH

    Background/Purpose: Hydralazine-induced ANCA-associated vasculitis (HIAAV) is a rare clinical problem.  There is paucity of data regarding clinical features, treatment, and prognosis of hydralazine-induced AAV in…
  • Abstract Number: 0196 • ACR Convergence 2024

    Associations Between Systemic Lupus Erythematosus (SLE) and the Social Vulnerability Index (SVI)

    Zoe Reed1, Xana Howard1, Cristina Arriens1, Teresa Aberle1, Wade DeJager2, Joan Merrill3 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, 3Oklahoma Medical Research Foundation, Oklahoma City 73104, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease that disproportionately affects young women of certain racial and ethnic minority groups with enhanced severity…
  • Abstract Number: 0489 • ACR Convergence 2024

    Use of Chair Sit-to-Stand as a Pragmatic Alternative to Assess Frailty in Rheumatoid Arthritis

    Hannah Brubeck1, Kylie Riggles2, Riley Bass3, Elizabeth Wahl4, James Andrews5, Namrata Singh6, ariela orkaby7, Joshua Baker8, Patti Katz9, Dolores Shoback10, Jose Garcia11 and Katherine Wysham12, 1VA Puget Sound Health Care System, Seattle, WA, 2VA Puget Sound Health Care System, Bellevue, WA, 3VA Puget Sound Health Care System, Seattle, 4VA Puget Sound Healthcare System, Seattle, WA, 5University of Alabama at Birmingham, Birmingham, AL, 6University of Washington, Bellevue, WA, 7New England VA Geriatric Research Education and Clinical Center/Boston VA/Division of Aging, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 8University of Pennsylvania, Philadelphia, PA, 9UCSF, San Rafael, CA, 10San Francisco VA/University of California, San Francisco, San Francisco, CA, 11VA Puget Sound Health Care System/University of Washington, Seattle, WA, 12VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA

    Background/Purpose: Frailty occurs earlier in people with rheumatoid arthritis (RA) than in the general population and is associated with poor health outcomes1, making it important…
  • Abstract Number: 0825 • ACR Convergence 2024

    Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator (BRAVO): 6-month Outcomes of a Longitudinal Cohort Study

    Arielle Mendel1, Lillian Barra2, Sasha Bernatsky3, Alison Clifford4, Mojtaba Dabaghjamanesh5, Natasha Dehghan6, Aurore Fifi-Mah7, Jean-Paul Makhzoum8, Rosalie-Sélène Meunier9, Nataliya Milman10, Medha Soowamber11, Jan Willem Cohen Tervaert12, Elaine Yacyshyn4, Nader Khalidi13 and Christian Pagnoux14, 1McGill University Health Centre, Montreal, QC, Canada, 2Western University, London, ON, Canada, 3Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 4University of Alberta, Edmonton, AB, Canada, 5Western University, Canada, Richmond Hill, ON, Canada, 6University of British Columbia - Vancouver, Vancouver, BC, Canada, 7University of Calgary, Calgary, AB, Canada, 8Vasculitis Clinic, Canadian Network for Research on Vasculitides, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada, 9Hôpital Sacré-Coeur, Université de Montréal, Montreal, QC, Canada, 10the Ottawa Hospital, Ottawa, ON, Canada, 11Mount Sinai Hospital, Woodbridge, ON, Canada, 12University of Alberta, Edmonton, Canada, 13McMaster University, Hamilton, ON, Canada, 14Mount Sinai Hospital, Toronto, ON, Canada

    Background/Purpose: To evaluate the effectiveness and safety of rituximab (RTX) biosimilars compared to the originator in Canadians with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis…
  • Abstract Number: 1209 • ACR Convergence 2024

    Time to Knee Replacement by Kellgren-Lawrence Grade and Presence of Frequent Knee Pain in Two Large and Diverse Longitudinal Cohorts: Data from MOST and OAI

    Kent Kwoh1, Rongrong Tang2, Edward Bedrick3, Jeffery Duryea4, Zong-Ming Li2, Jean Liew5, Xiaoxiao Sun6 and Tuhina Neogi5, 1University of Arizona, Tucson, AZ, 2University of Arizona Arthritis Center, University of Arizona College of Medicine - Tucson, Tucson, AZ, 3Department of Epidemiology andBiostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, 4Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 5Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 6Department of Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ

    Background/Purpose:  Receipt of knee replacement has been proposed by the FDA as a structural and symptom outcome for clinical trials of Disease Modifying Osteoarthritis Drugs…
  • Abstract Number: 1506 • ACR Convergence 2024

    Cognitive Impairment Prevalence and Most Affected Domains in Patients with SLE by the ACR Comprehensive Neuropsychological Battery

    Chrisanna Dobrowolski1, Juan Pablo Diaz Martinez2, Kathleen Bingham2, Michelle Barraclough3, Roberta Kretzmann2, Maria Carmela Tartaglia4, Lesley Ruttan5, May Choi6, Simone Appenzeller7, Sherief Marzouk2, Dennisse Bonilla2, Patti Katz8, Dorcas Beaton9, Robin Green2, Joan Wither2, Laura Patricia Whittall Garcia2, Dafna Gladman10 and Zahi Touma11, 1Icahn School of Medicine at Mount Sinai, New York, NY, 2University Health Network, Toronto, ON, Canada, 3The University of Manchester, Manchester, United Kingdom, 4University Health Network, University of Toronto, Toronto, ON, Canada, 5Toronto Rehab/University Health Network - University Centre, Toronto, Canada, 6University of Calgary, Calgary, AB, Canada, 7Unicamp, Campinas, SP, Brazil, 8UCSF, San Rafael, CA, 9Institute for Work & Health, Toronto, ON, Canada, 10University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 11University of Toronto, Toronto, ON, Canada

    Background/Purpose: Systemic lupus (SLE) has a well-established association with cognitive impairment (CI) and confers worse quality of life. We previously presented descriptive data regarding the…
  • Abstract Number: 1994 • ACR Convergence 2024

    Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study

    Javier Narvaez-García1, Arturo Llobell2, Andrés Ponce3, Antonio Gomez-Centeno4, Ana Milena Millán5, Hèctor Corominas5, Joan Miquel Nolla1 and Jose Alfredo Gomez-Puerta6, 1Hospital Universitario de Bellvitge, Barcelona, Spain, 2Hospital Universitario Parc Taulí, Sabadell, Spain, 3Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain, 4Hospital Quiron Barcelona, Barcelona, Spain, 5Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 6Rheumatology Department, Hospital Clinic of Barcelona, Barcelona, Spain

    Background/Purpose: To analyse the clinical presentation, treatment response, and outcomes of arthritis induced by immune checkpoint inhibitors (ICIs) in patients with cancer.Methods: Retrospective observational study conducted…
  • Abstract Number: 2241 • ACR Convergence 2024

    Associations Between Disease Activity, Physical Function and Anti-rheumatic Medications with All-cause Mortality in Rheumatoid Arthritis (RA): Data from a Canadian RA Registry

    Mohammad Movahedi1, Angela Cesta2, Xiuying Li2, Bindee Kuriya3, Sibel Aydin4, Ed Keystone5, Janet Pope6 and Claire Bombardier7, and OBRI investigators, 1Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 2UHN, Toronto, ON, Canada, 3University of Toronto - Toronto, Toronto, ON, Canada, 4Ottawa Hospital Research Institute, Ottawa, ON, Canada, 5Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 6University of Western Ontario, London, ON, Canada, 7University of Toronto, Toronto, ON, Canada

    Background/Purpose: Patients with rheumatoid arthritis (RA) are at increased risk of hospitalizations and mortality due to RA itself, associated comorbidities, and treatment-related complications. The purpose…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 28
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology